Praxis Precision Medicines Inc. (PRAX): Price and Financial Metrics


Praxis Precision Medicines Inc. (PRAX): $8.41

0.03 (+0.36%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRAX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

PRAX Stock Price Chart Interactive Chart >

Price chart for PRAX

PRAX Price/Volume Stats

Current price $8.41 52-week high $23.56
Prev. close $8.38 52-week low $7.25
Day low $8.06 Volume 425,400
Day high $8.50 Avg. volume 270,241
50-day MA $9.63 Dividend yield N/A
200-day MA $15.62 Market Cap 382.76M

Praxis Precision Medicines Inc. (PRAX) Company Bio


Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA.


PRAX Latest News Stream


Event/Time News Detail
Loading, please wait...

PRAX Latest Social Stream


Loading social stream, please wait...

View Full PRAX Social Stream

Latest PRAX News From Around the Web

Below are the latest news stories about Praxis Precision Medicines Inc that investors may wish to consider to help them evaluate PRAX as an investment opportunity.

Praxis Precision Medicines Announces Publication of Preclinical Data Highlighting Differentiated and Potent Antiepileptic Activity of PRAX-562

PRAX-562 demonstrated robust preclinical antiseizure activity and exhibited an improved preclinical tolerability profile compared to standard-of-care Praxis expects to initiate a Phase 2 trial in the first half of 2022 to explore the potential for PRAX-562 to treat rare DEEs BOSTON, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system

Yahoo | January 18, 2022

A number of insiders bought Praxis Precision Medicines, Inc. (NASDAQ:PRAX) stock last year, which is great news for shareholders

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | January 17, 2022

Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down to $19.01

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) gapped down before the market opened on Wednesday . The stock had previously closed at $19.01, but opened at $18.45. Praxis Precision Medicines shares last traded at $18.71, with a volume of 339 shares traded. Several research firms have weighed in on PRAX. Wedbush lowered their price target on shares []

Transcript Daily | December 22, 2021

HC Wainwright Initiates Coverage on Praxis Precision Medicines (NASDAQ:PRAX)

HC Wainwright initiated coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX) in a report published on Thursday, PriceTargets.com reports. The firm issued a buy rating and a $48.00 target price on the stock. PRAX has been the topic of several other reports. Bank of America started coverage on shares of Praxis Precision Medicines in a []

Transcript Daily | December 20, 2021

Analysts Anticipate Praxis Precision Medicines, Inc. (NASDAQ:PRAX) to Announce -$1.08 EPS

Wall Street analysts expect Praxis Precision Medicines, Inc. (NASDAQ:PRAX) to post earnings of ($1.08) per share for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Praxis Precision Medicines earnings. The highest EPS estimate is ($0.93) and the lowest is ($1.19). Praxis Precision Medicines posted earnings per share of ($0.87) []

Dakota Financial News | December 19, 2021

Read More 'PRAX' Stories Here

PRAX Price Returns

1-mo -2.10%
3-mo -36.91%
6-mo -50.79%
1-year -57.07%
3-year N/A
5-year N/A
YTD -57.31%
2021 -64.19%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4749 seconds.